๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› USA
Clinical trial register · United States · industry-sponsored

Industry-sponsored studies with a US investigative site

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors โ€” the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice โ€” all 9112 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 23 Sep 2026, 03:16 UTC
9112
Studies in scope
industry-sponsored, all four open statuses
4950
Recruiting now
open to new participants
2202
Lead sponsors
across recruiting studies
Top states
California 5295 Florida 4397 Illinois 2479 Georgia 2346 Arizona 2231
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca299 Novartis Pharmaceuticals202 Eli Lilly and Company190 Merck Sharp & Dohme LLC183 AbbVie172
State
California5295 Florida4397 Illinois2479 Georgia2346 Arizona2231
All 51 states
Target enrolment
to
9112 of 9112 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Active, closed
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
NCT04044859Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ), Gastric (Stomach) Cancer
USWM CT, LLC
Phase 1
120
Florida, Massachusetts, Missouri, New York, North Carolina, Oklahoma, Tennessee, Texas
2019-08-20
Active, closed
A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
NCT04002297Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
BeOne Medicines
Phase 3
510
California, Illinois, Massachusetts, Michigan, Nevada, New York, Oregon, Pennsylvania
2019-08-20
Recruiting
Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study
NCT03811171Renal Calculi, Urinary Calculi
SonoMotion
Not applicable
70
California, Washington
2019-08-20
Active, closed
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359Dermatitis Atopic
Sanofi
Observational
1,860
Alabama, Arizona, California, Florida, Georgia, Illinois, Indiana, Kentucky
2019-08-15
Active, closed
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
NCT04119050Warm Autoimmune Hemolytic Anemia
Janssen Research & Development, LLC
Phase 2/3
118
California, Colorado, Florida, Illinois, Kansas, Louisiana, Michigan, Missouri
2019-08-15
Active, closed
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
NCT04044768Synovial Sarcoma, Myxoid Liposarcoma
USWM CT, LLC
Phase 2
52
California, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri
2019-08-13
Active, closed
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
NCT04077723Lymphoma, Non-Hodgkin
Hoffmann-La Roche
Phase 1/2
498
California, Missouri, Texas
2019-08-13
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene
Phase 3
665
California, Florida, Illinois, Massachusetts, Michigan, New York, Ohio, Pennsylvania
2019-08-12
Active, closed
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
NCT04035005Multiple Sclerosis, Primary Progressive
Hoffmann-La Roche
Phase 3
1,013
District of Columbia, Florida, Kansas, Ohio, Pennsylvania
2019-08-12
Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
NCT03972657Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals
Phase 1/2
345
Arizona, California, Colorado, Connecticut, Florida, Massachusetts, Michigan, Minnesota
2019-08-12
Recruiting
Pan Tumor Rollover Study
NCT03899155Cancer
Bristol-Myers Squibb
Phase 2
1,500
Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Illinois
2019-08-09
Recruiting
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
NCT04068597Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma
CellCentric Ltd.
Phase 1/2
250
Georgia, Indiana, Maryland, Nebraska, Pennsylvania
2019-08-09
Active, closed
A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
NCT03779334Muscular Atrophy, Spinal
Hoffmann-La Roche
Phase 2
26
Florida
2019-08-07
Active, closed
MDR - Biomet Cannulated Screws
NCT04002518Fractures, Bone, Fracture Multiple
Zimmer Biomet
Observational
51
Indiana, Ohio, Virginia
2019-08-07
Active, closed
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C
NCT04012996Symptomatic Cervical Disc Disease
Centinel Spine
Not applicable
390
Arizona, California, Colorado, District of Columbia, Florida, Indiana, Kentucky, Louisiana
2019-08-05
Active, closed
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
NCT04008030Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 3
839
California, Colorado, Illinois, New York, Oregon, Pennsylvania, Texas, Virginia
2019-08-05
Recruiting
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
NCT03789552Chronic Stable Angina Pectoris
Tasly Pharmaceuticals, Inc.
Phase 3
765
Florida
2019-08-01
Active, closed
Omega3 Wound Fish Skin Graft in the Treatment of DFUs
NCT04133493Diabetic Foot Ulcer
Kerecis Ltd.
Not applicable
100
Florida, Georgia, Indiana, Ohio, Pennsylvania
2019-07-31
Recruiting
SUNOSIยฎ (Solriamfetol) Pregnancy Registry
NCT06413420Narcolepsy, Obstructive Sleep Apnea, Pregnant Women and Their Offspring
Axsome Therapeutics, Inc.
Observational
1,731
North Carolina
2019-07-31
Active, closed
A Clinical Study on Acurisโ„ข - Conometric Concept for Single Tooth Restoration
NCT04063878Jaw, Edentulous, Partially
Dentsply Sirona Implants and Consumables
Not applicable
160
Illinois, Oklahoma
2019-07-30
Active, closed
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
NCT03861273Hemophilia B
Pfizer
Phase 3
51
California, Colorado, Indiana, Mississippi, Pennsylvania
2019-07-29
Active, closed
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
NCT03949283Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer
Cordgenics, LLC
Phase 3
150
California, Florida, Louisiana, Ohio, Oklahoma, Pennsylvania, West Virginia
2019-07-26
Recruiting
Safety and Efficacy of Next Science Gel on Toenail Fungus
NCT04042857Onychomycosis of Toenail
Next Science TM
Not applicable
20
Florida
2019-07-26
Active, closed
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
NCT03814746Sickle Cell Disease (SCD)
Novartis Pharmaceuticals
Phase 3
254
Georgia, Massachusetts, North Carolina, Tennessee, Texas
2019-07-26
Recruiting
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
NCT04064359Solid Tumor
Oxford BioTherapeutics Ltd
Phase 1
200
Arizona, California, Florida, Iowa, Kentucky, Mississippi, New Mexico, New York
2019-07-25
Recruiting
GOREยฎ CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
NCT03821129Stroke, PFO - Patent Foramen Ovale
W.L.Gore & Associates
Not applicable
636
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Iowa
2019-07-25
Active, closed
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
NCT03924895Urinary Bladder Cancer, Muscle-invasive
Merck Sharp & Dohme LLC
Phase 3
595
Alabama, Arkansas, California, Colorado, District of Columbia, Georgia, Illinois, Indiana
2019-07-24
Active, closed
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
NCT03916627Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Head and Neck Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 2
65
New York
2019-07-23
Active, closed
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
NCT04046445Colorectal Cancer, MSS, Stage IV Colon Cancer, Stage IV Rectal Cancer
Amal Therapeutics
Phase 1
96
Arizona, California, Colorado, New York, North Carolina, Texas
2019-07-22
Active, closed
TARGET BP I Clinical Trial
NCT02910414Hypertension
Ablative Solutions, Inc.
Phase 3
300
Alabama, Georgia, North Carolina, Texas
2019-07-22
Active, closed
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
NCT03836040Migraine
Amgen
Phase 3
457
California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois, Indiana
2019-07-19
Active, closed
Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
NCT03992755Primary Pulmonary Hypertension
Liquidia Technologies, Inc.
Phase 3
92
Arizona, California, Colorado, Florida, Georgia, Illinois, Kansas, Louisiana
2019-07-18
Active, closed
Citadel Embolization Device Study
NCT04057352Unruptured Wide-neck Aneurysms
Stryker Neurovascular
Not applicable
150
California, Colorado, Florida, Illinois, Indiana, Kansas, Kentucky, Massachusetts
2019-07-18
Active, closed
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
NCT03981796Neoplasms
Tesaro, Inc.
Phase 3
785
Arizona, California, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky
2019-07-18
Active, closed
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
NCT03897881Melanoma
ModernaTX, Inc.
Phase 2
267
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2019-07-18
Recruiting
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
NCT04270591C-Met Exon 14 Mutation
Haihe Biopharma Co., Ltd.
Phase 1/2
183
Kentucky
2019-07-15
Active, closed
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
NCT04008797Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms
Eisai Inc.
Phase 1/2
301
Arkansas, California, Colorado, Florida, Louisiana, Mississippi, Missouri, New York
2019-07-11
Active, closed
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)
NCT03974022Non-Small Cell Lung Cancer
Dizal Pharmaceuticals
Phase 1/2
315
California, Colorado, Florida, Massachusetts, Michigan, New York, Ohio, Virginia
2019-07-09
Active, closed
Long Term Extension Study in Patients With Primary Hyperoxaluria
NCT04042402Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases, Urologic Diseases
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 3
75
California, Massachusetts, Minnesota, New York
2019-07-09
Active, closed
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropinยฎ Once a Day
NCT03878446Short Stature Children Born Small for Gestational Age (SGA)
Novo Nordisk A/S
Phase 2
62
Alabama, California, Idaho, Minnesota, New Jersey, New York, Ohio, Oklahoma
2019-07-04
Active, closed
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
NCT03978000Necrotizing Enterocolitis
Infant Bacterial Therapeutics
Phase 3
2,158
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois
2019-07-04
Active, closed
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
NCT04035486Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
587
California, Florida, Kansas, Kentucky, Massachusetts, Nevada, New York, Ohio
2019-07-02
By invitation
Development and Analysis of a Stool Bank for Cancer Patients
NCT04291755Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal
Persephone Biosciences
Observational
100
California, Florida
2019-06-28
Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
NCT03947385Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer, Other Solid Tumors
IDEAYA Biosciences
Phase 1/2
336
California, Colorado, Iowa, Michigan, New York, North Carolina, Ohio, Pennsylvania
2019-06-28
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Phase 1/2
217
California, Florida, Illinois, Kansas, Massachusetts, Pennsylvania, Tennessee, Texas
2019-06-26
Active, closed
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
NCT03944772Non-Small Cell Lung Cancer
AstraZeneca
Phase 2
247
California, Connecticut, Illinois, Maryland, Massachusetts, Michigan, New York, Oregon
2019-06-25
Active, closed
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
NCT03937219Renal Cell Carcinoma
Exelixis
Phase 3
855
California, Florida, Georgia, Illinois, Maine, Maryland, Massachusetts, Michigan
2019-06-25
Active, closed
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC
NCT03997123Triple Negative Breast Neoplasms
AstraZeneca
Phase 3
923
California, Florida, Illinois, Kansas, Maryland, Michigan, New York, Ohio
2019-06-25
Active, closed
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
NCT03933735Multiple Myeloma
AbbVie
Phase 1/2
220
California, Louisiana, Minnesota, Missouri, New York, North Carolina, Wisconsin
2019-06-24
Active, closed
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
NCT03725007Juvenile Idiopathic Arthritis (JIA)
AbbVie
Phase 1
124
Illinois, Kentucky, Massachusetts, Ohio, Oregon, Pennsylvania, Washington
2019-06-24
Active, closed
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
NCT03876769B-Cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Phase 2
121
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Indiana
2019-06-24
Active, closed
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
NCT03873402Renal Cell Carcinoma
Bristol-Myers Squibb
Phase 3
437
District of Columbia, Georgia, Massachusetts, Pennsylvania, South Carolina
2019-06-21
Active, closed
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
NCT03851068Aortic Valve Disease, Aortic Valve Stenosis
Foldax, Inc
Not applicable
40
Indiana, Kansas, Michigan, Ohio
2019-06-18
Active, closed
remedฤ“ System Therapy Study
NCT03884660Central Sleep Apnea
Respicardia, Inc.
Observational
225
Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky, Michigan
2019-06-18
Recruiting
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
NCT03659448Colorectal Neoplasms
Surgimab
Phase 3
300
California, Florida, Massachusetts, Pennsylvania
2019-06-17
Active, closed
Evaluation of the GOREยฎ EXCLUDERยฎ Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
NCT03728985Thoracoabdominal Aortic Aneurysm
W.L.Gore & Associates
Not applicable
102
Alabama, Arizona, California, District of Columbia, Florida, Georgia, Illinois, Indiana
2019-06-17
Recruiting
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
NCT03796559Breast Cancer, Axillary Lymph Nodes
Endomagnetics Ltd.
Not applicable
65
Texas
2019-06-13
Active, closed
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
NCT03899792Medullary Thyroid Cancer, Infantile Myofibromatosis, Infantile Fibrosarcoma, Papillary Thyroid Cancer
Eli Lilly and Company
Phase 1/2
36
California, Colorado, Florida, Massachusetts, Minnesota, New York, Ohio, Pennsylvania
2019-06-13
Active, closed
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
NCT03989947Achondroplasia
BioMarin Pharmaceutical
Phase 2
73
California, Delaware, Georgia, Illinois, Ohio, Tennessee, Texas, Wisconsin
2019-06-12
Active, closed
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
NCT03161431Melanoma Stage III, Melanoma Stage IV
Syntrix Biosystems, Inc.
Phase 1
77
Florida, Massachusetts, Minnesota, New York, Texas
2019-06-12
Active, closed
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
NCT03767244Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 3
2,517
California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana, Massachusetts
2019-06-11
Active, closed
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NCT03735667Aortic Stenosis
Boston Scientific Corporation
Not applicable
1,948
Alabama, Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Illinois
2019-06-10
Recruiting
Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
NCT05678530Cardiopulmonary
Prolaio
Observational
2,000
Arizona, California, Delaware, Florida, Illinois, Minnesota, Texas, Utah
2019-06-06
Active, closed
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
NCT03957252Prostate Cancer, Prostate Cancer Screening, Performance Assessment of Novel Test
Nanostics
Observational
2,800
Maryland
2019-06-06
Recruiting
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
NCT03817502Schizophrenia
Gedeon Richter Plc.
Phase 3
330
California, Georgia, Michigan, Mississippi, New York, Ohio, Texas
2019-06-06
Active, closed
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
NCT03969004Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3
415
Arizona, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Maryland
2019-06-04
Active, closed
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
NCT04015141Pediatric Epileptic Syndrome, Partial-onset Seizures
Eisai Inc.
Phase 2
100
California, Colorado, Florida, Georgia, Michigan, New Jersey, North Carolina, Ohio
2019-05-31
By invitation
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
NCT03999801Neovascular Age-related Macular Degeneration, Wet Macular Degeneration
AbbVie
Phase 2
865
Arizona, California, Maryland, Massachusetts, Nevada, Pennsylvania, Tennessee, Texas
2019-05-31
Active, closed
A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)
NCT03773393Bone Marrow Disease
Cellenkos, Inc.
Phase 1
18
California, Texas
2019-05-30
Active, closed
Effisayilโ„ข ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study
NCT03886246Generalized Pustular Psoriasis
LEO Pharma
Phase 2
131
Michigan, New York
2019-05-29
Active, closed
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
NCT03709680Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor, Rhabdomyosarcoma
Pfizer
Phase 2
128
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2019-05-24
Active, closed
Evaluation of the Safety and Efficacy of TLD in Patients with COPD
NCT03639051COPD
Nuvaira, Inc.
Not applicable
464
Alabama, Arizona, California, Florida, Illinois, Kentucky, Massachusetts, Michigan
2019-05-23
Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
NCT03808922Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19
Ansun Biopharma, Inc.
Phase 3
274
California, Illinois, Iowa, Kansas, Maryland, Massachusetts, Minnesota, Missouri
2019-05-23
Active, closed
Safety and Performance Study of the Legion Porous System in Total Knee Arthroplasty
NCT03720782Total Knee Arthroplasty
Smith & Nephew, Inc.
Observational
118
Minnesota, Missouri
2019-05-22
Active, closed
An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
NCT04053803Sickle Cell Disease
Imara, Inc.
Phase 2
30
Connecticut, Florida, Texas
2019-05-22
Active, closed
Case-Control Study of the Glycotestโ„ข HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
NCT03878550Carcinoma, Hepatocellular, Cirrhosis, Liver
Glycotest, Inc.
Observational
766
California, Florida, Illinois, Maryland, Michigan, Minnesota, New York, Pennsylvania
2019-05-22
Active, closed
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
NCT03893955Cancer, Advanced Solid Tumors, Triple-Negative Breast Cancer (TNBC), Non-small-cell-lung-cancer (NSCLC)
AbbVie
Phase 1
150
Arkansas, California, Connecticut, Florida, Indiana, Missouri, North Carolina, Pennsylvania
2019-05-21
Recruiting
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT05181826Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B
Helio Genomics
Observational
1,200
California, Minnesota, Tennessee, Texas
2019-05-21
Active, closed
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
NCT03927261Acute Myeloid Leukemia, Myelodysplastic Syndromes
Precigen, Inc
Phase 1
88
Florida, Minnesota
2019-05-20
Active, closed
The Assessment of Human Sleep and Its Functions
NCT07211646Insomnia
StimScience Inc.
Not applicable
1,000
California
2019-05-20
Active, closed
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
NCT03930953Lymphoma, Non-Hodgkin
Celgene
Phase 1/2
438
Arizona, Florida, Kansas, Minnesota, Missouri, New Jersey, Texas
2019-05-20
Recruiting
ACTengineยฎ IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
NCT03686124Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Immatics US, Inc.
Phase 1/2
375
California, Colorado, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania
2019-05-14
Recruiting
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
NCT03480971Mucositis, Nephrotoxicity, Ototoxicity
Matrix Biomed, Inc.
Phase 2
120
California, New York, North Carolina, Washington
2019-05-13
Active, closed
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
NCT03752827Rotator Cuff Tear, Rotator Cuff Tendinitis
InGeneron, Inc.
Not applicable
168
Arizona, California, Florida, Georgia, Louisiana, Michigan, North Dakota, South Dakota
2019-05-13
Active, closed
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
NCT03769506Head and Neck Cancer
Rakuten Medical, Inc.
Phase 3
135
Florida, Georgia, Kentucky, Pennsylvania, Texas
2019-05-09
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Arkansas, California, Florida, Illinois, Indiana, Kentucky, Louisiana, Massachusetts
2019-05-09
Active, closed
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
NCT03811561Diabetes Mellitus, Type 2
Novo Nordisk A/S
Phase 3
1,500
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana
2019-05-08
Active, closed
A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
NCT03899649Stage III Pancreatic Cancer
Angiodynamics, Inc.
Observational
532
California, Florida, Georgia, Illinois, Iowa, Kentucky, Minnesota, Missouri
2019-05-08
Active, closed
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
NCT03891953Carcinoma, Non-Small-Cell Lung, Melanoma, Nasopharyngeal Carcinoma, Microsatellite Stable Colorectal Cancer
Novartis Pharmaceuticals
Phase 1
98
Massachusetts, Tennessee
2019-05-07
Active, closed
A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
NCT03952078T-cell Lymphoma
Corvus Pharmaceuticals, Inc.
Phase 1
151
California, Michigan, Missouri, New Jersey, Ohio, Pennsylvania
2019-05-03
Active, closed
Assessment of Medherent Medication Management Device and Adherence Platform
NCT03775044Mental Health Disorder, Medication Adherence
Terrapin Pharmacy
Not applicable
150
Maryland
2019-05-01
Active, closed
Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease
NCT03808103Crohn Disease
Intralytix, Inc.
Phase 1/2
30
Maryland, New York
2019-05-01
Active, closed
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
NCT03478462Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor, DIPG
Cellectar Biosciences, Inc.
Phase 1
30
California, New York, North Carolina, Ohio, Texas, Wisconsin
2019-04-30
Active, closed
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT03907527Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Carcinoma
Precigen, Inc
Phase 1
71
Maryland, Washington
2019-04-30
Active, closed
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
NCT03847428Hepatocellular Carcinoma
AstraZeneca
Phase 3
908
Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Kansas
2019-04-29
Recruiting
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
NCT03633708Secondary Hyperparathyroidism, Chronic Kidney Disease
Amgen
Phase 3
56
California, Colorado, Missouri, New York, Ohio, Oklahoma, Pennsylvania, Texas
2019-04-29
Active, closed
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
NCT03872947Solid Tumor, Colorectal Cancer, Cholangiocarcinoma, Bladder Cancer
Toray Industries, Inc
Phase 1
138
Arizona, California, Louisiana, New Jersey, New York, Oregon, Texas, Virginia
2019-04-26
Active, closed
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
NCT03104517Stress Urinary Incontinence
Cook MyoSite
Phase 3
96
Arizona, California, District of Columbia, Kansas, Michigan, New Mexico, New York, North Carolina
2019-04-23
Active, closed
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
NCT03875235Biliary Tract Neoplasms
AstraZeneca
Phase 3
810
California, District of Columbia, Florida, Kansas, Kentucky, Massachusetts, Missouri, North Carolina
2019-04-16
Active, closed
(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis
NCT03731260Indolent Systemic Mastocytosis
Blueprint Medicines Corporation
Phase 2
251
Alabama, Arizona, California, Florida, Georgia, Illinois, Kansas, Massachusetts
2019-04-16
Rows per page Showing 8401–8500 of 9112
Previous 83 84 85 86 87 Next
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-usa?page=85

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →
→

Browse trials by condition

Advanced Solid Tumor (143) Breast Cancer (139) Obesity (123) Multiple Myeloma (109) Advanced Solid Tumors (89) Colorectal Cancer (83) Solid Tumor (81) Overweight (77) Ovarian Cancer (74) Healthy (73) Prostate Cancer (73) Heart Failure (72) Non-Small Cell Lung Cancer (70) Cancer (65) Melanoma (63)
→

Browse trials by state

California (5295) Florida (4397) Illinois (2479) Georgia (2346) Arizona (2231) New York (2126) Colorado (2066) Texas (1969) Massachusetts (1836) Michigan (1481) Alabama (1288) Connecticut (1274) Maryland (1267) Ohio (1252) Indiana (1114)
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.